OrphanDrug
OrphanDrug
Pharma Knowledge Base

drug-induced autoimmune hemolytic anemia

ICD-10: D59.0ORPHA: 90037

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Drug-induced autoimmune hemolytic anemia is a type of autoimmune hemolytic anemia (AIHA; see this term) that occurs as a reaction to therapeutic drugs, and can be due to various mechanisms

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with drug-induced autoimmune hemolytic anemia, sourced from HPO and Orphanet clinical annotations.

PallorMuscle weaknessCongestive heart failureTachycardiaSplenomegalyAutoimmune hemolytic anemiaHeadacheExertional dyspneaIncreased total bilirubinAbnormal urinary colorFatigue

Classification & Codes

ICD-10 Code

D59.0

Orphanet Code

ORPHA:90037
drug-induced autoimmune hemolytic anemia
ICD-10D59.0
OrphanetORPHA:90037
Treatments0 drug(s)
Symptoms on record11 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
drug-induced autoimmune hemolytic anemia | OrphanDrug